Examining whether lung screening changes risk perceptions: national lung screening trial participants at 1 year follow-up.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Works matching IS 14696886 AND DT 2013 AND VI 7 AND IP 1
Results: 24
1
2
The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
3
Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
4
Rapid on-site cytologic evaluation during endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) for nodal staging in patients with lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
5
Lung cancer detection with digital chest tomosynthesis. Baseline results from the observational study SOS.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
6
Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in subtyping of non-small cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
7
Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
8
Distinctive histopathological features of lepidic growth predominant node negative adenocarcinomas 3-5 cm in size.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
9
Definition of a positive test result in computed tomography screening for lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
10
A 12-gene set predicts survival benefits from adjuvant chemotherapy in non-small cell lung cancer patients/Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma/Predictive impact of circulating vascular endothelial growth factor in four Phase III trials evaluating bevacizumab.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
11
Adenosquamous carcinoma of the lung: surgical management, pathologic characteristics, and prognostic implications.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
12
Prognostic factors in resected pathological N1-stage II nonsmall cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
13
A multicenter Phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
14
Incremental risk of prior coronary arterial stents for pulmonary resection.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
15
Morbidities of lung cancer surgery in obese patients/National perioperative outcomes of pulmonary lobectomy for cancer in the obese patient: a propensity score matched analysis.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
16
Survival after extended resection for mediastinal advanced lung cancer: lessons learned on 167 consecutive cases.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
17
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
18
Relevance of extensive follow-up after surgery for non-small cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
19
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
20
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
21
Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
22
International Events 2013.
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 7, n. 1, p. 10
- Publication type:
- Article
23
Foreword.
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 7, n. 1, p. 1
- Publication type:
- Article
24
Chronic Refractory Breathlessness in Lung Cancer: Characteristics and Symptomatic Management.
- Published in:
- Current Medical Literature: Lung Cancer, 2013, v. 7, n. 1, p. 1
- By:
- Publication type:
- Article